Meadows A T, Kramer S, Hopson R, Lustbader E, Jarrett P, Evans A E
Cancer Invest. 1983;1(1):49-55. doi: 10.3109/07357908309040932.
The objective of this study was to determine the effect of place and type of initial treatment on survival from acute lymphocytic leukemia (ALL). Every one of the 327 children under 15 years of age diagnosed with ALL from 1970 to 1975 in a 31-county area designated the Greater Delaware Valley, were studied. Treatment according to protocol was associated with improved survival, yielding a 4 year survival of 60% vs 19% for nonprotocol treated patients (p less than 0.001). There was also a significantly improved survival rate among patients treated in a cancer center, especially for those with a low white blood count (WBC) at diagnosis. The prognostic importance of WBC, age, and sex was confirmed.
本研究的目的是确定初始治疗地点和类型对急性淋巴细胞白血病(ALL)患者生存率的影响。对1970年至1975年在指定为大特拉华谷的31个县区域内诊断出患有ALL的327名15岁以下儿童均进行了研究。按照方案进行治疗与生存率提高相关,方案治疗患者的4年生存率为60%,而非方案治疗患者为19%(p<0.001)。在癌症中心接受治疗的患者生存率也显著提高,尤其是那些诊断时白细胞计数(WBC)较低的患者。白细胞计数、年龄和性别的预后重要性得到了证实。